1. Weir GC, Leahy JL, Bonner-Weir S. Experimental reduction of B-cell mass: Implications for the pathogenesis of diabetes. Diab Metab Rev 2:125–1611986.
3. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islet to streptozotocin. Limited B-cell regeneration and hyperglycemia. Diabetes 30:64–691981.
4. Weir GC, clore ET, Zmachinski CJ, Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 30:590–5951981.
5. Leahy JL, Bonner-Weir S, Weir GC. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33:667–6731984.
7. Folgia VG. Caracteristicas de la diabetes en la rata. Rev Soc Argent Biol 20:21–371944.
8. Weibel ER. Principles and methods for the morphometric studies of the lung and other organs. Lab Invest 12:131–1551963.
10. Hamilton RL, Berry MN, Williams MC, Severinghaus EM. A simple and inexpensive membrane “lung” for small organ perfusion. J Lipid Res 15:182–1861974.
11. Albano JDM, Ekins RP, Maritz G, Turner RC. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70:487–5091972.
12. Snedecor GW, Cochran WG. Statistical Methods. Iowa State University Press, Ames: 1967.
13. Chick WL. Beta cell replication in rat pancreatic monolayer cultures: effects of glucose tolbutamide, glucocorticoid, growth hormone and glucagon. Diabets 22:687–6931973.
14. Bonner-Weir S, Deery D. Selective growth of adult B-cells is seen during short term in vivo glucose infusions. Diabetes 36(Suppl 1):6A. 1987.
15. Hellerstrom CF, Swenne I, Andersson A. Islet cell replication and diabetes. In: Lefeb vre P, Pipeleers D, eds. The Pathology of the Endocrine Pancreas in Diabetes. Springer-Verlag, Heidelberg: In Press. 1987.
16. McCulloch DK, Raghu PK, Klaff LJ, Koerker DJ, Palmer JP. Impaired glucose potentiation of arginine-stimulated insulin release is a sensitive and reliable marker of B-cell damage. Diabetes 34(Suppl 1):85A. 1985.
17. Ward WK, Taborsky GJ, Beard JC. Reduced maximal potentiation of the insulin response to arginine: a sensitive indicator of B-cell damage. Diabetes 35(Suppl 1):98A. 1986.
18. Nesher R, Waldman L, Cerasi E. Time-dependent inhibition of insulin release: glucose-arginine interactions in the perfused rat pancreas. Diabetolodgia 26:146–1491984.
19. DePirro R, Green A, Yung-Chin Kao M, Olefsky JM. Effects of prednisolone and dexamethasone in vivo and in vitro: studies of insulin binding, deoxyglucose uptake, and glucose oxidation in rat adipocytes. Diabetologia 21:149–1531981.
21. Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC. Limited B-cell regeneration in a B-cell deficient rat model: Studies with dexamethasone. Metabolism 30:914–9181981.
22. Weir GC. Non-insulin-dependent diabetes mellitus: interplay between B-cell inadequacy and insulin resistance. Am J Med 73:461–4641982.
23. Unger RH, Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes. Diabetologia 28:119–1211985.
24. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15:417–4211978.
25. Saito K, Yaginuma N, Takahashi T. Differential volumetry of A,B, and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 129:273–2831979.
26. Klöppel G, Löhr M, Hablich H, Oberholzer M, Heitz PU. Islet pathology and pathogenesis of the 1 and 2 diabetes mellitus revisited. Surv Synth Path Res 4:110–1251985.
27. Wrenshall GA, Bogoch A, Ritchine RC. Extractable insulin of pancreas. Correlation with pathological and clinical findings in diabetic and nondiabetic cases. Diabetes 1:87–1071952.
28. Rastogi GK, Sinha MK, Dash RJ. Insulin and proinsulin content of pancreases from diabetic and nondiabetic subjects. Diabetes 22:804–8071973.
29. Tasaka Y, Marumo K, Inoue Y, Hirata Y. C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level. Acta Endocrinol 113:355–3621986.